Michael Gordon Bio

Michael Gordon is a member of the firm’s Executive Committee, as well as the head of the New York M&A and Private Equity Group. He represents both buyers and sellers of public and private companies, as well as issuers, underwriters and investors in a variety of offerings of common stock, preferred stock, convertible securities and debt securities. Michael maintains a substantial practice in mergers and acquisitions, working on domestic and global transactions for a variety of clients, including businesses, private equity firms, hedge funds, special board committees and financial advisors. Strong leadership in advising clients has earned Michael acknowledgment in numerous industry publications, including the “Top 50 M&A Lawyers for 2018” list by The Deal. He was also recognized in the 2014 and 2016 editions of LMG Life Sciences, which named him a “Life Science Star” in the category of Finance & Transactional. Michael has been featured in Chambers USA, Law360, AMLaw Daily, REIT magazine, The Legal 500 US and, based on a vote of peers, recognized in Super Lawyers magazine in the area of Mergers & Acquisitions. His practice has also been highlighted in articles in the American Lawyer, the Chicago Tribune and Bloomberg. He was also named a BTI Client Service All-Star for 2015 and 2016 based on a survey of corporate counsel from more than 250 Fortune 1000 companies by BTI Consulting. Michael’s work also features international transactions, with particular emphasis on cross-border merger and acquisition, joint venture and investment transactions involving China. Working closely with Sidley’s offices in China, Michael represents both financial and strategic investors in connection with investments in Chinese and other Asian companies.